Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition) has been released in Sep. 2024. Based on the 2023 edition, the 2024 edition of the guideline has been updated concerning lung cancer screening, pathological evaluation, surgical standards, neoadjuvant therapy, postoperative adjuvant therapy and treatment of advanced lung cancer. This article gives a brief introduction and interpretation on these updated points.